citalopram and vofopitant

citalopram has been researched along with vofopitant in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahs, F; Appel, L; Bani, M; Bergström, M; Flyckt, K; Fredrikson, M; Furmark, T; Grohp, M; Jacobsson, E; Långström, B; Michelgård, A; Nilsson, LG; Pich, EM; Wahlstedt, K; Zancan, S	1
Bourin, M; Chenu, F; Gardier, AM; Guiard, BP	1
Bouchez, G; Brocco, M; Dekeyne, A; Di Cara, B; Gannon, RL; Gobert, A; Lejeune, F; Millan, MJ	1
Åhs, F; Appel, L; Bani, M; Bettica, P; Fredrikson, M; Frick, A; Furmark, T; Jonasson, M; Långström, B; Lubberink, M; Merlo Pich, E; Wahlstedt, K	1

Trials

2 trial(s) available for citalopram and vofopitant

Article	Year
Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo. Biological psychiatry, 2005, Jul-15, Volume: 58, Issue:2 Topics: Adult; Anxiety; Cerebrovascular Circulation; Citalopram; Double-Blind Method; Female; Humans; Male; Neurokinin-1 Receptor Antagonists; Phobic Disorders; Piperidines; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Temporal Lobe; Tetrazoles	2005
Reduced serotonin synthesis and regional cerebral blood flow after anxiolytic treatment of social anxiety disorder. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2016, Volume: 26, Issue:11 Topics: Adult; Amygdala; Anti-Anxiety Agents; Cerebrovascular Circulation; Citalopram; Double-Blind Method; Female; Humans; Kinetics; Male; Neurokinin-1 Receptor Antagonists; Phobia, Social; Piperidines; Positron-Emission Tomography; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin; Social Environment; Stress, Psychological; Tetrazoles	2016

Article

Year

Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo.

Biological psychiatry, 2005, Jul-15, Volume: 58, Issue:2

Topics: Adult; Anxiety; Cerebrovascular Circulation; Citalopram; Double-Blind Method; Female; Humans; Male; Neurokinin-1 Receptor Antagonists; Phobic Disorders; Piperidines; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Temporal Lobe; Tetrazoles

2005

Reduced serotonin synthesis and regional cerebral blood flow after anxiolytic treatment of social anxiety disorder.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2016, Volume: 26, Issue:11

Topics: Adult; Amygdala; Anti-Anxiety Agents; Cerebrovascular Circulation; Citalopram; Double-Blind Method; Female; Humans; Kinetics; Male; Neurokinin-1 Receptor Antagonists; Phobia, Social; Piperidines; Positron-Emission Tomography; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin; Social Environment; Stress, Psychological; Tetrazoles

2016

Other Studies

2 other study(ies) available for citalopram and vofopitant

Article	Year
Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test. Behavioural brain research, 2006, Sep-25, Volume: 172, Issue:2 Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Antidepressive Agents; Citalopram; Depressive Disorder; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Escape Reaction; Male; Mice; Neurokinin-1 Receptor Antagonists; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Swimming; Tetrazoles	2006
Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:4 Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Brain; Citalopram; Cricetinae; Dopamine; Drug Synergism; Fluoxetine; Gerbillinae; Isoindoles; Male; Mesocricetus; Mice; Neurokinin-1 Receptor Antagonists; Neurons; Norepinephrine; Piperidines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Tetrazoles	2009

Article

Year

Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test.

Behavioural brain research, 2006, Sep-25, Volume: 172, Issue:2

Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Antidepressive Agents; Citalopram; Depressive Disorder; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Escape Reaction; Male; Mice; Neurokinin-1 Receptor Antagonists; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Swimming; Tetrazoles

2006

Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:4

Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Brain; Citalopram; Cricetinae; Dopamine; Drug Synergism; Fluoxetine; Gerbillinae; Isoindoles; Male; Mesocricetus; Mice; Neurokinin-1 Receptor Antagonists; Neurons; Norepinephrine; Piperidines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Tetrazoles

2009